Dr
Richard
Williams

Partner & Patent Attorney

London Office

Telephone. +44(0) 207 776 5100
Mobile. +44(0) 792 177 1931
Email. [email protected]

Experience

Richard has more than 30 years continuous working experience in private practice. He has encountered a broad and varied spectrum of possible situations and scenarios involving all sorts of IP challenges and requirements.

Certain essential elements of patent work align well with Richard's character. He enjoys the sense of chase he gets in fact finding and "stone turning". This means Richard is very adept at peeling back the layers of any matter to get quickly to the heart of it, legally, technically and commercially. He also has a particularly well-honed radar for identifying risk and opportunity, and then a creative imperative and internal driver to match. Richard finds the combinations of these skills serves him well in generating excellent cost effective commercial solutions to whatever patent challenges he is presented with.

Broadly, Richard's technical knowledge and experience comes under IPC codes: A01, A21, A22, A23, A24, A61, B01, B09, B82, C02, C04, C11, C12 (C12N, C12 Q), C13, C25 and C40.

More specifically: CRISPR; gene editing; riboswitches, nucleic acid sequencing; PCR based assays; nucleic acid-based diagnostics; antibodies (therapeutic or diagnostic), immunoaffinity purification; chimeric T cells and therapies; miRNA, siRNA, oncology; biomarkers; bioinformatics; enzymes; epigenetics; modified bacteria, viruses, algae, fungi, plants, insects (mosquitoes), fish and fish feed, animals, plant secondary compounds; oligosaccharides; pest control; plant breeding tools; plant protection products; biodegradable packaging; sewage treatments; human pharmaceutical formulations (small molecules, proteins, antibodies); vaccines (anticancer, influenza); medical devices; ocular devices, diagnostics and therapies.

Specialisms

  • Agbio
  • Bioinformatics
  • Bioprocessing
  • Diagnostics
  • Gene editing technologies

Industries

  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Strategy
  • Transactional IP & commercial support

Qualifications

Patent Attorney

Chartered (UK)
European


MA

Natural Science (Oxon)

LLM

Patent Litigation (Nottingham Trent)

PHD

Plant Science (Wales)

Recognition

Legal 500

“…excellent knowledge, experience and analytical acumen…”. (Legal 500 - 2011) “…superb…”’ (Legal 500 - 2012)

Conferences: 2019

November 28th 2019

Management Forum: Intellectual Property Protection for Plant Innovation 2019

Speaker

Event details

November 28th 2019

IP Protection for Plant Innovation 2019 - Amsterdam

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.